Table 2.
Outcome profile inclusion study systematic review and meta-analysis
| References | Types of fillers (trade name) | Increase in penile diameter, mm (mean±SD) | Improved penile appearance satisfaction, VAS score* (mean±SD) | Increased sexual satisfaction, VAS score* (mean±SD) | Pain events (n) | Penile inflammatory events (n) |
|---|---|---|---|---|---|---|
| Yang et al.5 2019a | Hyaluronic acid (Chaeum Shape) | 20.6±10.9 | 1,59±1.13 | 1.13±1.24 | 0 | 0 |
| Polylactic acid (PowerFill) | 14.6±10.4 | 1.5±1.26 | 0.88±1.56 | 1 | 1 | |
| Yang et al.22 2019b | Hyaluronic acid (Neuramis Deep) | 21±10 | 1.7±1.7 | 1.1±1 | 0 | 1 |
| Polylactic acid (PowerFill) | 16±9 | 1.7±1.4 | 0.4±1.1 | 2 | 0 | |
| Yang et al.6 2020 | Hyaluronic acid (Hyafilia Impact) | 19.1±14.9 | 1.2±1.1 | 1.1±0.9 | 2 | 1 |
| Polylactic acid (PowerFill) | 19.5±10.8 | 1.4±1 | 0.9±1.2 | 1 | 1 | |
| Ahn et al.17 | Hyaluronic acid (Doublofill) | 22.7±12.6 | TD | 1.16±1.07 | 0 | 2 |
| Polylactic acid (PowerFill) | 20.2±8.73 | TD | 0.42±0.89 | 1 | 2 |
*
VAS Score: Visual Analogue Scale Score